In August 2020, Bayer announced it would pay $1.6 billion to end most of the U.S. Essure lawsuits involving women who claimed the birth control device caused serious health complications. Bayer had ...

Rybelsus and Ozempic are both prescription semaglutide medications used to help control blood sugar levels in patients with Type 2 diabetes. The main difference is that Ozempic is an injection and ...

Continuous glucose monitors (CGMs) provide near real‑time blood glucose data for people with diabetes. Studies show they can improve glycemic control and increase the time spent in a normal blood ...

FreeStyle Libre sensors are wearable continuous glucose monitoring (CGM) devices that measure glucose and send frequent readings to a compatible reader or smart device. Libre 3 and Libre 3 Plus ...

Patients may experience various hernia mesh complications after hernia repair surgery. The most common hernia mesh complications are persistent pain, infection, hernia recurrence, adhesion and bowel ...

Tylenol lawsuits claim the companies that manufacture and sell Tylenol failed to warn of the increased risks of autism and ADHD in children whose mothers took Tylenol. In July 2026, an appeals court ...

Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by The Wilson Firm LLP, we've pursued justice for more ...

Roundup, the most widely used herbicide in the U.S., contains the active ingredient glyphosate. While its effectiveness as a weed killer is undeniable, there is debate over whether Roundup use causes ...

Pharmaceutical company Endo International primarily focuses on pain management, with Percocet among its most widely recognized painkillers. Endo added urology and medical devices after acquiring ...

Retatrutide is an experimental drug currently being tested for obesity and Type 2 diabetes. Clinical trials have drawn attention to it because early results suggest it may lead to some of the most ...

In February 2026, Bayer announced a new $7.25 billion Roundup settlement to resolve current and future cancer claims. That settlement will need to be approved by a judge. It could resolve tens of ...

Thousands of lawsuits allege hair relaxers cause uterine, ovarian and endometrial cancer, and that brands like L'Oréal and Revlon failed to warn consumers of the risks. Lawsuits also allege ...